Leadership

Mary Duseau

President

Mary joins Molecular Devices with more than 25 years of experience in the Life Science Market holding roles of increasing responsibility in sales, marketing and business management.

Prior to joining Molecular Devices, she served as Senior Vice President, Commercial Management at Leica Biosystems, a Danaher company. Before joining Danaher, Mary was CEO and President for Roka Bioscience and prior to this, Senior Vice President, Sales for Andor Technologies and Global Vice President, Sales and Marketing for PerkinElmer. Additionally, at PerkinElmer, she held the role of Business Unit Leader, Imaging and Detection, focused in the Drug Discovery and Development market.

She holds a BS in Biochemistry, from the University of Massachusetts.

Hema Sundarraj

Chief Financial Officer

Hema Sundarraj serves as Chief Financial Officer of Molecular Devices, where she leads the global Finance organization to support strategic execution, accelerate growth, and strengthen financial and operational performance.

Most recently, she was Chief Financial Officer at Phenomenex, a Danaher operating company within the Life Sciences platform. In this role, she drove strong financial results and supported growth initiatives by enhancing working capital management, leading strategic investments, and advancing the company’s IT and eCommerce capabilities. She is also known for building high-performing, engaged teams.

Previously, Hema held senior finance leadership roles at Cepheid, Applied Materials, Nanometrics, Mattson Technology, and Sunpreme. Her experience spans public and private companies, as well as growth-stage organizations.

Hema holds an MBA in Finance and Marketing from XLRI Jamshedpur and is an inactive CPA in the state of California.

Lars Hartvig Kristiansen

Vice President, Product Innovation & Strategy

Lars Hartvig Kristiansen is Vice President of Product Innovation & Strategy, responsible for leading strategic initiatives, driving innovation, and overseeing the global product management team. He leads cross-functional efforts to grow the business through M&A, licensing, and partnerships, while guiding strategic planning and execution across the company.

Lars brings over a decade of experience in life sciences and management consulting. At Agilent Technologies, he held senior roles across strategy, operations, and M&A, including leading strategic growth initiatives for the $4B Life Sciences group and most recently serving as General Manager, running the Global Automation Solutions P&L. He holds Bachelor’s and Master’s degrees in Engineering from Aalborg University, with a focus on Technology Management and Supply Chain.

Dan Green

Vice President of Research and Development

Dan was appointed Vice President of R&D in June of 2020. He previously served as the Senior Director of BioImaging R&D since September of 2018 and Senior Director of Software since April of 2015. He has been with Molecular Devices and its predecessor companies since 1988, when he joined Universal Imaging Corporation as a software developer. Since then he has held a variety of technical and leadership roles of increasing responsibility. Dan holds a MS in Computer Science from the University of Illinois at Urbana-Champaign, and a BA from Cornell University, Ithaca NY

Krishnapal Solanki

Vice President, DBS

As a Vice President - DBS, Krishnapal oversees all the continuous improvement effort globally across all the functions. Krishnapal Joined Molecular Devices in November 2021 bringing over 13 years of experience leading various functions across 3 different Danaher operating companies.

Krishnapal’s Danaher journey started as a customer (life science research) which later converted into a Danaher associate at Leica Microsystems as a Sr. Field Service Engineer and worked in a variety of progressive roles such as a Regional Supervisor of Field Service Operations, Growth Manager for the Americas, Sr Manager Sales & Marketing at Cepheid and most recently Director of DBS Innovation at Molecular Devices . Krishnapal is proficient and certified in Danaher process improvement tools like DM/VM, Funnel Management and PSP and has facilitated and led Kaizen workshops for cross functional teams at various Danaher opcos. His work expertise includes installing and maintaining all 3 DBS engines (Commercial, Innovation and Service) to drive over all organizational growth. Krishnapal is also involved in DE&I activities and been a Members Engagement Lead at Asian Descent + Friends ARG at Danaher from 2021-2022.

Krishnapal holds Master of Science degree Biomedical Engineering from UT Arlington and SW Medical Center Dallas. He holds Bachelor of Engineering degree in Biomedical Engineering from India.

Lakshmi Sailaja Eleswarapu

Vice President, IT

As Vice President of IT for SCIEX, Molecular Devices, and Danaher Life Sciences, Lakshmi Eleswarapu champions global IT strategy, fostering technological innovation and organizational excellence. Her role extends to supporting the Danaher Life Sciences Innovation Group (LSIG) commercial team and contributing to the L1 team at Molecular Devices. Her tenure includes significant achievements in business transformation, M&A IT integrations, and diversity initiatives. Lakshmi's career spans 26 years in IT, with the last 16 years dedicated to Danaher, positioning her to drive future innovation and growth.

Lakshmi holds a Bachelor’s in Mathematics with Honors from SSSIHL University (India) and a Master’s in Computer Applications from Osmania University (India).

Ray Li

Vice President of Global Operations

Ray Li, Vice President of Global Operations, brings nearly 18 years of invaluable experience to Molecular Devices. Since joining in 2007 as a Manufacturing Engineer, Ray has held key roles including Production Manager, Production Manager & DBSL, Operations Manager, and Shanghai Plant General Manager, with Salzburg added to his responsibilities in 2022. In his new role, Ray will drive progress by enhancing operational efficiency and fostering innovation across global operations. Based in Shanghai, his extensive background and strategic vision make him a vital asset to our leadership team.

Tracy Clarke

Vice President of Service

Tracy Clarke, Vice President of Service, brings over 30 years of experience in the laboratory and medical industry to Molecular Devices. With a remarkable 17-year tenure at Leica Biosystems, Tracy excels in building high-performing teams, managing complex projects, and driving continuous improvement. As Senior Director of Service at Leica, she led a team of 210 professionals, managed a $96M P&L, and consistently drove customer satisfaction and revenue growth. Tracy is committed to enhancing our customers’ experience, building service capabilities, fostering strong cross-functional relationships, and promoting an inclusive culture.

Tracy Clarke, holds a master’s degree in Veterinary Medical Science and a Bachelor’s degree in Molecular Biology & Cell Science from the University of Florida.

Yang Shi

Vice President, Global Commercial

Yang Shi, Ph.D., MBA, is Vice President of Global Commercial at Molecular Devices, where he leads a worldwide team spanning Sales, Field Applications, Customer Service, and Sales Operations. He brings extensive commercial leadership experience from across Danaher, including roles at SCIEX, Phenomenex, and Integrated DNA Technologies (IDT).

Most recently, he served as Vice President of Americas Sales at IDT and previously as Vice President of Global Sales at Phenomenex. Earlier in his career, Yang advanced scientific innovation as a Senior Scientist with Waters Corporation, Thermo Fisher Scientific, and the Sanford Burnham Institute.

Yang holds a Ph.D. in Chemical Engineering from Yale University, an MBA from the University of Massachusetts–Amherst, and B.S. and M.S. degrees in Biochemical Engineering from Tianjin University.